Former Meta and Time Warner exec Mark D’Arcy is joining Microsoft as a corporate vice president working on the tech giant’s ...

Hims & Hers Health (NYSE:HIMS) priced its offering of $870M aggregate principal amount of 0.00% convertible senior notes due ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Hims & Hers Health (NYSE:HIMS) experienced a remarkable 97% share price increase over the past month, a move that coincided with significant executive changes. The appointment of Mo Elshenawy as Chief ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.

Hims & Hers ( HIMS 19.03%) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth ...

Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...

Hims & Hers Health ( HIMS) shares surged 8% Tuesday, a day after the health and wellness platform posted better-than-expected ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...